DeFloria Advancing Charlotte’s Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug LOUISVILLE, Colo. and WASHINGTON, Dec. 19, 2025 /PRNewswire/ – DeFloria Inc., a botanical drug development Company recognizes the Presidential Executive Order…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the “Selling Stockholder”), has determined not to pursue the public offering of 2,000,000 shares […]
ODAC on Thursday voted overwhelmingly against keeping the accelerated approval for Sweden-based Oncopeptides’ Pepaxto, voting 14 “no,” and 2 “yes” to the FDA’s question of: “is the benefit-risk profile of melphalan flufenamide favorable for the […]
Announces Completion of More than 80 Successful Cloud ERP Migrations to Date LOUISVILLE, Colo., July 14, 2022 /PRNewswire/ — Global Healthcare Exchange (GHX) today shared business highlights from its Cloud portfolio during the first half […]
Copyright © 2026 Biotech Networks
